241
MED R2

MCQ R2

Embed Size (px)

Citation preview

Page 1: MCQ R2

MED R2

Page 2: MCQ R2

A 22 year old man with acute myeloid leukemia was treated with allogenic bone marrow transplant 3 months ago. He received cyclosporin 200 mg/day and cotrimoxazole. He had fever and nonproductive cough for 2 days prior to this admission. On physical examination revealed fever 38.3 c and fine crepitationboth lungs. He had no skin rash. The CXR was bilateral interstitial infiltrations.

What is the MOST likely diagnosis?

A. PCP pneumoniaB. Mycoplasma pneumoniaC. CMV pneumoniaD. Staphylococcus pneumoniaE. Aspergillus pneumonia

Page 3: MCQ R2

Respiratory complication after HSCT

Page 4: MCQ R2

Immune system after HSCT

Phase I (pre engraftment) 0-30 days

Host defence deficits

1 Neutropenia

2 Damage mucocutaneous barrier translocation of GI and cutaneous bacteria to bloodstream

3 Indwelling intravenous catheter septic emboli

Page 5: MCQ R2

Organism

Bacteria

gram negative Klebsiella, Pseudomonas, Enterobacteriaceae

gram positive Staphylococcus (coagulase postiveand negative), Enterococcus

Fungus

Candida spp, Aspergillois

Virus

HSV

Page 6: MCQ R2

• Risk for infection

– Allogenic = Autologous

• Resolve

– ANC > 500, platelet > 20,000 * 3 days

Page 7: MCQ R2

Phase II ( 30-100 days)

• Decrease or discontinue corticosteroid restore PMN function decrease risk for bacteria and funfus

BUT

Still has immune system dysfunction especially

Decreased CD4/CD8 ratio

Decreased IgA, IgG

Increased risk forCMVPJP Aspergillosis

Page 8: MCQ R2

Allogenic HSCT

Acute GVHD

skin, GI and liver manifestration

Page 9: MCQ R2

Phase III ( > 100 days)

Cellular and humoral immune deficit

macrophage dysfunction, impaired PMN chemotaxic

long lasting IgA and IgG deficiency

Risk for

encapsulated organism ( S.pneumoniae, H.influenza, N.meningitidis)

Norcadia,mycoplasma

PCP

CMV

Page 10: MCQ R2

• Allogenic HSCT chronic GVHD

bronchiolitis obliteran

scleroderma

sicca syndrome

Page 11: MCQ R2

Febrile neutropenia AIDS

Page 12: MCQ R2

A 22 year old man with acute myeloid leukemia was treated with allogenic bone marrow transplant 3 months ago. He received cyclosporin 200 mg/day and cotrimoxazole. He had fever and nonproductive cough for 2 days prior to this admission. On physical examination revealed fever 38.3 c and fine crepitationboth lungs. He had no skin rash. The CXR was bilateral interstitial infiltrations.

What is the MOST likely diagnosis?

A. PCP pneumoniaB. Mycoplasma pneumoniaC. CMV pneumoniaD. Staphylococcus pneumoniaE. Aspergillus pneumonia

Suppress T cell

Rapid onset of fever ,non productive cough,dyspnea and hypoxemia Interstitial pattern with tiny pulmonary nodules

Page 13: MCQ R2
Page 14: MCQ R2

Staphylococcus pneumonia

Page 15: MCQ R2

Arterial blood gas was drawn from a 16 year-old female immediately after her intubation for a severe asthmatic attack. PaO2 was 350 mm Hg, PaCO2 was 50 mm Hg and pH was 7.30. She remained sedated and paralyzed, breathing at the machine set rate of 12 /min and with a tidal volume of 400 cc. What should the rate be to normalize PaCO2 at 40 mmHg?

A. 14B. 15C. 16D. 17E. 18

Page 16: MCQ R2

ALVEOLAR VENTILATION EQUATION

หากผูป่้วยม ีCO2 production คงที ่ดงัน ัน้คา่

PACO2 เป็นตวับอก alveolar ventilation

• PACO2 มคีา่ใกลเ้คยีงกบั PaCO2 มาก

Page 17: MCQ R2

VT

VD

VA

VT = VA + VD หรอื VA = VT – VDAlveolar ventilation = RR x VA = RR (VT-VD)

Page 18: MCQ R2

“Alveolar ventilation equation”

PACO2 = k x VCO2/RR (VT-VD)

Page 19: MCQ R2

“Alveolar ventilation equation”

PACO2 = k x VCO2/RR (VT-VD)

PaCO21 = k x CO2 production 1PaCO22 alveolar ventilation 1

k x CO2 production 2alveolar ventilation 2

Page 20: MCQ R2

PaCO21 = alveolar ventilation 2PaCO22 alveolar ventilation 1

= [Vt(2)-Vd(2)] x RR(2)

[Vt(1)-Vd(1)] x RR(1)

“Alveolar ventilation equation”

Page 21: MCQ R2

VT เท่าเดมิ

PaCO21 = [Vt(2)-Vd(2)] x RR(2)

PaCO22 [Vt(1)-Vd(1)] x RR(1)

50 = RR(2)

40 12

RR(2) = 15/min

Page 22: MCQ R2

Arterial blood gas was drawn from a 16 year-old female immediately after her intubation for a severe asthmatic attack. PaO2 was 350 mm Hg, PaCO2 was 50 mm Hg and pH was 7.30. She remained sedated and paralyzed, breathing at the machine set rate of 12 /min and with a tidal volume of 400 cc. What should the rate be to normalize PaCO2 at 40 mmHg?

A. 14

C. 16D. 17E. 18

Page 23: MCQ R2

A 30 year old woman, previously healthy, develop smear positive pulmonary TB. After receiving INH, RIF, Ethambutol and PZA one daily before bedtime for 1 week, she developed progressive nausea vomiting and malaise, the physical findings are unremarkable. The LFT reveals: TB/DB 2.8/1.6, AST/ALT 180/170, Alk phos 150.

What is the MOST immediate appropiatemanagement?

A. Switch to ethambutol, olfoxacin and streptomycinB. Stop only PZA and continue the rest 3 drugsC. Replace RIF with olfloxacinD. Add domperidoneE. Split INH to 3 times daily after meal

Page 24: MCQ R2

A 30 year old woman, previously healthy, develop smear positive pulmonary TB. After receiving INH, RIF, Ethambutol and PZA one daily before bedtime for 1 week, she developed progressive nausea vomiting and malaise, the physical findings are unremarkable. The LFT reveals: TB/DB 2.8/1.6, AST/ALT 180/170, Alk phos 150.

Page 25: MCQ R2
Page 26: MCQ R2
Page 27: MCQ R2
Page 28: MCQ R2
Page 29: MCQ R2

Management of drug-induced hepatitis

Of the first-line anti-TB drugs, isoniazid, pyrazinamide and rifampicin can all cause liver damage (drug-induced hepatitis).

Try to rule out other possible causes before deciding that the hepatitis is induced by the TB regimen.

The management of hepatitis induced by TB treatment depends on:

whether the patient is in the intensive or continuation phase

the severity of the liver disease

the severity of the TB

the capacity of the health unit to manage the side-effects of TB treatment

Page 30: MCQ R2

If liver disease is caused by the anti-TB drugs all drugs should be stopped.

If the patient is severely ill with TB and it is unsafe to stop TB treatment non-hepatotoxic regimen consisting of streptomycin, ethambutol and fluoroquinolone should be started

Page 31: MCQ R2

• If TB treatment has been stopped wait for LFT to revert to normal and clinical symptoms (nausea, abdominal pain) to resolve restart the anti-TB drugs.

• If it is not possible to perform LFT wait an extra 2 weeks after resolution of jaundice and upper abdominal tenderness before restarting TB treatment.

• If the signs and symptoms do not resolve and the liver disease is severe non-hepatotoxic regimen consisting of streptomycin, ethambutol and a fluoroquinoloneshould be started (or continued) for a total of 18–24 months

Page 32: MCQ R2

When resolve rechallenge antiTB one by one.

If symptoms recur or LFT abnormal after rechallengelast drug added should be stopped.

In patients who have experienced jaundice but tolerate the rechallenge of rifampicin and isoniazid, it is advisable to avoid pyrazinamide.

Page 33: MCQ R2

Drug causes hepatitis

Rifampicin

2SHE 10 HE

INH

6-9 REZ

PZA

2 HRE 7 HR

INH and RIF

18-24 EOS

Page 34: MCQ R2

A 30 year old woman, previously healthy, develop smear positive pulmonary TB. After receiving INH, RIF, Ethambutol and PZA one daily before bedtime for 1 week, she developed progressive nausea vomiting and malaise, the physical findings are unremarkable. The LFT reveals: TB/DB 2.8/1.6, AST/ALT 180/170, Alk phos 150.

A. Switch to ethambutol, olfoxacin and streptomycinB. Stop only PZA and continue the rest 3 drugsC. Replace RIF with olfloxacinD. Add domperidoneE. Split INH to 3 times daily after meal

Page 35: MCQ R2

A 65 year old man, 50 kg, was recently diagnosed with active pulmonary TB. He was started on INH 300 mg/day, RIF 600 mg/day, ethambutol 800 mg/day and PZA 1500 mg/day. After 2 weeks of treatment, he complaint of nausea after taking medication. LFT showed AST 130 ALT 120 Alk phos 100, normal TB and DB.

What is the MOST appropiate management>

A. Continue medications, close follow up LFT and symptomsB. Stop all medications, follow up LFT, restart medications

after LFT normalizeC. Stop only INH but continue others, follow up LFTD. Switch to streptomycin, ethambutol and ofloxacinE. Decrease PZA to 1000 mg/day and follow up LFT

Page 36: MCQ R2

A 65 year old man, 50 kg, was recently diagnosed with active pulmonary TB. He was started on INH 300 mg/day, RIF 600 mg/day, ethambutol 800 mg/day and PZA 1500 mg/day. After 2 weeks of treatment, he complaint of nausea after taking medication. LFT showed AST 130 ALT 120 Alk phos 100, normal TB and DB.

What is the MOST appropiate management>

Active + symptom + AST/ALT > 3 times

A. Continue medications, close follow up LFT and symptomsB. Stop all medications, follow up LFT, restart medications

after LFT normalizeC. Stop only INH but continue others, follow up LFTD. Switch to streptomycin, ethambutol and ofloxacinE. Decrease PZA to 1000 mg/day and follow up LFT

Page 37: MCQ R2

ผลขา้งเคียงยาวณัโรค

Page 38: MCQ R2
Page 39: MCQ R2
Page 40: MCQ R2

Which one is incorrect reguarding the toxicity of antiTBdrugs?

A. PZA and hepatitis

B. Ethambutol and retrobulbar neuritis

C. Rifampicin and peripheral neuropathy

D. Streptomycin and renal toxicity

E. Isoniazid and hepatotoxicity

Page 41: MCQ R2

Side effect of antiTB drugs

Isoniazid

Systemic or cutaneous hypersensitivity reactions

Sleepiness or lethargy

Peripheral neuropathy, optic neuritis, toxic psychosis and generalized convulsions

hepatitis

lupus-like syndrome, pellagra, anemia, and arthralgias

monoamine (histamine/tyramine) poisoning

Page 42: MCQ R2

RifampicinOrange discoloration of body fluids pruritis with/without rashSevere Hypersensitivity HepatotoxicityTransient asymptomatic hyperbilirubinemiaHepatitis cholestatic pattern Influenza like syndrome GI upset : Nausea, anorexia, abdominal pain Immunological reaction : thrombocytopenia,

hemolytic anemia ,acute renal failure

Page 43: MCQ R2

Pyrazinamide

gastrointestinal intolerance

hypersensitivity reactions

rises in serum transaminase concentrations

hepatotoxicity

hyperuricaemia

Arthralgia

Rare adverse events sideroblastic anaemia and photosensitivity dermatitis

Contraindication in porphyria

Page 44: MCQ R2

Streptomycin

Hypersensitivity reactions are rare.

nephrotoxicity

ototoxicity

vertigo

Page 45: MCQ R2

EthambutolRetrobulbar neuritis (blurred vision, central scotomata, red-green color

blindness) : dose related

50 mg/kg : 15%

25 mg/kg : 1%- 5%

15 mg/kg : < 1%

Peripheral neuritis : rare

Cutaneous reaction

Monitoring VA, color

1. Dose > 15-25 mg/kg

2. Receive drug > 2 month

3. Renal insuff.

Discontinue drug immediatley and permanent if there any sign of visual toxicity

Page 46: MCQ R2

Which one is incorrect reguarding the toxicity of antiTBdrugs?

A. PZA and hepatitis

B. Ethambutol and retrobulbar neuritis

C. Rifampicin and peripheral neuropathy

D. Streptomycin and renal toxicity

E. Isoniazid and hepatotoxicity

INH

Page 47: MCQ R2

Which effect of rifampicin is absolute contraindication for prescribing it in future?

A. Flu like symptoms

B. Hepatitis

C. Maculopapular rash

D. Urine discoloration

E. Immune thrombocytopenia

Page 48: MCQ R2

Contraindication for remedication

• RFP: thrombocytopenia , hemolytic anemia , acute interstitial nephritis

• Etham : visual impairment

• strep : eight nerve damage

• PZA: jaundice

Page 49: MCQ R2

Management of cutaneous reaction

Itching without rash

symptomatic Rx with antihistamine and continue anti TB drug

Rash

stop all anti TB

when resolved restart one by one with small challenge dose

Page 50: MCQ R2
Page 51: MCQ R2

Which effect of rifampicin is absolute contraindication for prescribing it in future?

A. Flu like symptoms

B. Hepatitis

C. Maculopapular rash

D. Urine discoloration

E. Immune thrombocytopenia

Page 52: MCQ R2

Isoniazid Bactericidal

Rifampicin Bactericidal

Ethambutol Bacterioistatic

Pyrazinamide Weakly bactericidal

streptomycin Bactericidal

Page 53: MCQ R2

CNS penetration

Renal excretion

Pregnancy

INH Excellent Safe Safe

Rifam 10-20% of serum level

Safe Safe

PZA CNS = serum Should reduce limit data but benefit > risk

Etham Only inflammation

Should reduce Safe

Streptomycin

Slight Used with caution

X

(fetal hearing loss)

Page 54: MCQ R2

Dose

(mg/kg/day)

Cycloserine

Cs

Bacteristatic 10-15 bid

(500-750)

Ethionamide

Et

Bactericidal 15-20 od/bid

(500-750)

Amikacin /

kanamycin / Capreomycin

Am/Km/Cm

Bactericidal 15 IM/IV

5-7 day/weeks

(750-1,000)

Complete X resistant

between Am/Km but

Sm resistant are susceptible to Am/Km

PAS Bacteristatic 150 bid/tid

(8-12 g)

Ofloxacin

O

Bactericidal 7.5-15

(600-800)

X resistant between O

Cx and levofloxacin

Divalent ion interfere absorption

Ciprofloxacin

Cx

Bactericidal 10-20

(1,000-1,500)

Page 55: MCQ R2
Page 56: MCQ R2
Page 57: MCQ R2
Page 58: MCQ R2

AFB per ml Number of colonies

on cultureCulture report

Number of AFB on smear

(1000X, Ziehl-Nelsen)

Number of

AFB on smear(200-250X

,Fluorescen)

AFB smear

report

< 10 0 - 0 0 -

10-500 < 50 Actual count

0 0 -

500-1,000 50-100 1+ 0 0 -

1,000-2,000 100-200(almost confluent)

2+ 0 0 -

2,000-5,000 >500 (confluent) 3+ 1-2 / 300 field

1-2 / 30 field

5,000-60,000 >500 (confluent) 4+ 1-9 / 100 field

1-9 / 10 field

1+

60,000-600,000

>500 (confluent) 4+ 1-9 / 10 field

1-9 / field 2+

600,000-6,000,000

>500 (confluent) 4+ 1-9 / field 10-90 / field

3+

6,000,000-60,000,000

>500 (confluent) 4+ > 9 / field > 90 / field 4+

Page 59: MCQ R2

A patient with AIDS was admitted due to severe dyspnea. CXR showed bilateral upper lobe infiltratonand sputum smear showed AFB4+. He was isolated with air borne precaution. On transport him to radiology department for CT chest, you would advise:

A. Surgical mask formpateint and N 95 mask for trolley pusherB. Surgical mask for patient and trolley pusherC. N 95 mask for patient and surgical mask for trolley pusherD.N 95 mask for patient and trolley pusherE. N 95 mask for patient only

Page 60: MCQ R2

Airborne precaution

• ห้องแยก

• Sputum pot

• N 95 mask

• Surgical mask• เคลื่อนย้ายผู้ ป่วย

Particle < 5 um

• ปิดประตตูลอดเวลา

• ควรใช้ห้องความดนัอากาศเป็นลบ

• ใช้ HEPA filter ก่อนปลอ่ยอากาศออกจากห้อง

• ภาชนะมีฦาปิดให้เติม 2%lysol หรือ 5% hypochloride

• สวมเม่ือเข้าใกล้ผู้ ป่วย

• ผู้ ป่วยสวม

• สวมsurgical mask ให้ผู้ ป่วย

โรคที่พบChicken pox pulmonary tuberculosisHZV measleSARS

Page 61: MCQ R2

A patient with AIDS was admitted due to severe dyspnea. CXR showed bilateral upper lobe infiltratonand sputum smear showed AFB4+. He was isolated with air borne precaution. On transport him to radiology department for CT chest, you would advise:

A. Surgical mask formpateint and N 95 mask for trolley pusherB. Surgical mask for patient and trolley pusherC. N 95 mask for patient and surgical mask for trolley pusherD.N 95 mask for patient and trolley pusherE. N 95 mask for patient only

Page 62: MCQ R2

A 63 year old man, a 30 pack year smoker, present with increasing cough with sputum production, fever and progressive weight loss. He worked in a stone quarry for 20 years.

Which one of following in UNLIKELY to be found in is current evaluation?

A. Infection caused by Mycobacteria tuberculosisB. Malignant mesotheliomaC. Upper lobe lung noduleD. Eggshell calcificationE. Positive ANA in serum

Page 63: MCQ R2

A 63 year old man, a 30 pack year smoker, present with increasing cough with sputum production, fever and progressive weight loss. He worked in a stone quarry for 20 years.

Which one of following in UNLIKELY to be found in is current evaluation?

Silica dust

Page 64: MCQ R2

Diseases associated with exposure to silica dust

Slilicosis

chronic silicosis

accelerated silicosis

acute silicosis

progressive massive fibrosis

COPD

emphysema

chronic bronchitis

small airway

Mycobacterial infection

MTB

NTM

Immune related

PSS

RA

CRF

SLE

Page 65: MCQ R2

Silicosis

Page 66: MCQ R2

Risk factors for TB

• HIV

• Hematologic malignancy and cancer chemotherapy

• DM

• Uremia

• Undernutrition

• Gastrectomy

• Silicosis ( increased risk 2-30 times)

Page 67: MCQ R2

Risk factor of mesothelioma

asbestos exposure

ionizing radiation

chronic inflammation of pleura Mediterranianfever

Page 68: MCQ R2

A 63 year old man, a 30 pack year smoker, present with increasing cough with sputum production, fever and progressive weight loss. He worked in a stone quarry for 20 years.

Which one of following in UNLIKELY to be found in is current evaluation?

A. Infection caused by Mycobacteria tuberculosisB. Malignant mesotheliomaC. Upper lobe lung noduleD. Eggshell calcificationE. Positive ANA in serum

Page 69: MCQ R2

PAHFc II

Page 70: MCQ R2

Thai guideline for Dx and Rx PH 2011

Pulmonary hypertension

mean pulmonary arterial pressure >= 25 mmHg

Pulmonary arterial hypertension

mean pulmonary arterial pressure >= 25 mmHg

PCWP < 15 mmHg

PVR > 3 wood

Page 71: MCQ R2

Pulmonary hypertension Diagnostic classification

JACC June 2009:54(1)suppl S: S43-541.4

1.Pulmonary arterial hypertension

1.1. Idiopathic (IPAH)

1.2. Familial (FPAH)

1.3. Associated with (APAH):

1.3.1. Connective tissue disorder

1.3.2. Congenital systemic-to-pulmonary shunts

1.3.3. Portal hypertension

1.3.4. HIV infection

1.3.5. Drugs and toxins

1.3.6. Other (thyroid disorders, glycogen storage disease,Gaucher’s disease, hereditary hemorrhagic

telangiectasia,

hemoglobinopathies, chronic myeloproliferative disorders, splenectomy)

Page 72: MCQ R2

1.4. Associated with significant venous or capillary involvement

1.4.1. Pulmonary veno-occlusive disease (PVOD)

1.4.2. Pulmonary capillary hemangiomatosis (PCH)

1.5. Persistent pulmonary hypertension of the newborn

1.Pulmonary arterial hypertension

Page 73: MCQ R2

2. Pulmonary hypertension with left heart disease

2.1. Left-sided atrial or ventricular heart disease

2.2. Left-sided valvular heart disease

3. Pulmonary hypertension associated with lung diseases and/or hypoxemia3.1. Chronic obstructive pulmonary disease3.2. Interstitial lung disease3.3. Sleep disordered breathing3.4. Alveolar hypoventilation disorders3.5. Chronic exposure to high altitude3.6. Developmental abnormalities

Page 74: MCQ R2

4. Pulmonary hypertension due to chronic thrombotic and/or embolic disease (CTEPH)4.1. Thromboembolic obstruction of proximal pulmonary arteries4.2. Thromboembolic obstruction of distal pulmonary arteries4.3. Nonthrombotic pulmonary embolism (tumor, parasites,foreign material)

Page 75: MCQ R2

5. MiscellaneousSarcoidosis, histiocytosis X, lymphangiomatosis, compression of pulmonary vessels (adenopathy,tumor, fibrosing mediastinitis)

Page 76: MCQ R2

แนวทางการวินิจฉัย PH

ขัน้ตอนที่ 1 (PH diagnosis)

ขัน้ตอนที่ 2 (PH classicication)

Hx and PECXREKGEchoRHC

Blood test :antiHIV Cr LFT CBC ANAO2Sat, ABGCTA or V/QPFTPSGRHC

Page 77: MCQ R2

แนวทางการรักษา PAH

PAH

Avoid pregnancyInfluenza and pneumococcal

vaccinationExercisePsychosocial support

DiureticO2Oral anticoagulantDigoxin

Acute vasoreactivity test

Page 78: MCQ R2

Acute vasoreactivity test

vasoreactive

Fc I-IIICCB

Good response

yes no

Continue CCB

Poor response

Non vasoreactive/ not perform

PAH specific drug

F/U 3-6 month

Poor response

Combination Tx

Atrial septostomyLung transplant

Page 79: MCQ R2

ค าแนะน า Fc II Fc III Fc IV

1++ Sildenafil, bosentan Sidenafil, bosentan, iloprost inhaled

2++ Iloprost IV/inhaleCmbination Rx

3+ beraprost Bosentan, sidenafil

Page 80: MCQ R2
Page 81: MCQ R2
Page 82: MCQ R2

OSA; criteria for Dx

Symptom

PSG AHI >=5/hr + R/O other disease

No symptom

PSG AHI >= 15/hr + R/O other disease

Page 83: MCQ R2

Risk factor of OSA

1 neck size > 17 inches in male and > 16 inches in female

2 nasal feature eg polyp3 lingual feature eg

macroglossia4 palatal feature eg low lying

soft palate5 enlarge tonsil and adenoid6 oropharynx narrowing7 hereditar syndrome eg

Down syndrome

8 smoking9 obesity10 hypothyroid, acromegaly11 neuro eg stroke, Dchene12 alcohol13 medication BZs14 familial Hx of OSA15 ESRD16 CHF17 HT

Page 84: MCQ R2

Symptoms

1 excessive daytime sleepiness

2 morning headache

3 nocturia

4 nocturnal chocking

5 witnessed apnea

Page 85: MCQ R2

Consequences

1 HT2 CAD esp nocturnal ischemia3 arrhymia esp sinus arrhymia, bradycardia, sinus pause,

sinus arrest, VT PVC, AV block4 CHF in Pt with LVEF < 45%, AHI > 15 increase mortality5 PH6 Insulin resistance7 Erectile dysfunction8 depression9 GERD10 stroke11 floppy eyelid syndrome, gluacoma,papilledema

Page 86: MCQ R2

Rx

1 CPAP

2 uvulopalatopharyngeaopasty

3 oral appliance in mild to moderate pt

4 oromaxillofacial Sx

5 tracheostomy GOLD STANDARD

6 positional Rx

7 weight reduction

Page 87: MCQ R2
Page 88: MCQ R2

A truck driver, with BMI 25 Kg/m2, keeps falling asleep. He loses of muscle tone when he laughs with joking TV program. Sleep study shows no sleep apnoea, arousal index 26 times /hour and very short sleep latency. What is the most appropriate management?

A. uvuloplastyB. methylphenidateC. weight reductionD. sleep hygiene and reassure E. continuous positive airway pressure

Page 89: MCQ R2

A truck driver, with BMI 25 Kg/m2, keeps falling asleep. He loses of muscle tone when he laughs with joking TV program. Sleep study shows no sleep apnoea, arousal index 26 times /hour and very short sleep latency. What is the most appropriate management?

Page 90: MCQ R2

Classic tetrad

Excessive daytime sleepiness (EDS)

Cataplexy : an loss of skeletal muscle tone (triggered by the occurrence of sudden emotion)Sleep paralysis : a brief loss of voluntarymuscle control with an inability to move or speakHypnagogic Hallucinations : visual or auditory and occasionally involve other senses e.g., tactile or vestibular

NARCOLEPSY

Page 91: MCQ R2

NARCOLEPSY

Nonpharmacologic Management

Pharmacologic Management

Behavioral approaches

Scheduled naps (15-20 min, 2-3 times/day)

Regular sleep wake schedule

Avoidance of frequent time zone changes

Good sleep hygiene

modafinil and armodafinil

sodium oxybate, amphetamines, methylphenidate

Page 92: MCQ R2

63. A truck driver, with BMI 25 Kg/m2, keeps falling asleep. He loses of muscle tone when he laughs with joking TV program. Sleep study shows no sleep apnoea, arousal index 26 times /hour and very short sleep latency. What is the most appropriate management?

A. uvuloplasty

C. weight reductionD. sleep hygiene and reassure E. continuous positive airway pressure

Page 93: MCQ R2

A 60-year-old nonsmoker female with a 2-cm left upper lung nodule found on her check-up. She was asymptomatic and chest CT scan showed no evidence of hilar or mediastinal adenopathy but eccentric calcification was demonstrated within the nodule. What is the most appropriate management?

A. Left upper lobe lobectomy

B. Follow up CXR within 2 months

C. Review her last year CXR, if available

D. Empirical treatment with anti-TB drugs: HRZE

E. Percutaneous transthoracic needle aspiration

Page 94: MCQ R2

A 60-year-old nonsmoker female with a 2-cm left upper lung nodule found on her check-up. She was asymptomatic and chest CT scan showed no evidence of hilaror mediastinal adenopathy but eccentric calcification was demonstrated within the nodule. What is the most appropriate management?

Page 95: MCQ R2

Solitary pulmonary nodule

• Focal, round or oval areas of increased opacity

• Defined as <3 cm

• Not associated with atelectasis or adenopathy

• 90% incidental findings

Page 96: MCQ R2

Solitary pulmonary nodule

• Most SPN: benign

• 30-40% of SPN are malignant

• Patients with best prognosis are stage IA:

61-75% 5-year survival

Page 97: MCQ R2

Differential diagnosis

Neoplasm Benign Hamartoma

Inflammory pseudotumor

Malignant Bronchogenic carcinoma

Carcinoid tumor

Lymphoma (NHL)

Metastasis

Infection Granuloma Mycobacteria

Fungi

Septic emboli

Abscess Bacteria (anaerobes, Staph, gram negative)

Round pneumonia

Pneumococci

Parasitic Echinococcus

Dirofilaria (dog heartworm)

(Leef III JL, Klein JS. The solitary pulmonary nodule. Radiol Clin N Am 2002;40:123-143

Solitary pulmonary nodule

Page 98: MCQ R2

Differential diagnosisInflammatory CNT Wegener’s

granulomatosis

Rheumatoid nodule

Sarcoidosis

Vascular AVM

Hematoma

Pulmonary infarct

Pulmonary artery aneurysm

Pulmonary venous varices

Airway Congenital lesion Bronchogenic cyst

Bronchial atresia

Mucocele

Infected bulla

Leef III JL, Klein JS. The solitary pulmonary nodule. Radiol Clin N Am 2002;40:123-143

Solitary pulmonary nodule

Page 99: MCQ R2

Solitary pulmonary nodule

• 95% fall into one two groups

- Malignant: either primary or metastatic

- Benign

Infectious ;granulomas (either TB or

fungal)

Benign tumors: hamartomas present in

middle age, grow slowly over years

Page 100: MCQ R2

Solitary pulmonary nodule

• First step: ensure that the nodule is in fact

solitary and truly arises in the lung parenchyma.

• Up to 20% prove to be entities mimicking a SPN

Page 101: MCQ R2

Pseudonodule (a) Close-up PA radiograph of the right lung shows a smoothly marginated nodular area of increased opacity projecting over the lung (arrow).

(b) Front and back views of the EKG lead attachment pad

Erasmus JJ. Radiographics 2000;20:43-58

Solitary pulmonary nodule

Page 102: MCQ R2

Bone island in a 61-year-old man with melanoma. (a) Close-up PA CXR shows a focal area of increased opacity overlying the right seventh rib posteriorly (arrow). (b)Fluoroscopic images show a well-marginated intraosseous lesion (arrow). This finding is consistent with a bone island and obviated further investigation.

Erasmus JJ. Radiographics 2000;20:43-58

Solitary pulmonary nodule

Page 103: MCQ R2

Diagnostic evaluation

Second step

Aim to distinguish benign VS malignant

• Clinical features

• Radiographic features

• Quantitative models : used to determine the probability that the nodule is malignant

Page 104: MCQ R2

Clinical features

• Age - Risk of malignancy increases with age

– 3% at age 35-39 years

– 15% at age 40-49 years

– 43% at age 50-59 years

– greater than 50% in patients > 60 years

• Smoking history

• History of prior malignancy

Solitary pulmonary nodule

Manocha S, Sharma S. Solitary pulmonary nodule. http://www.emedicine.com/radio/topic782.ht

Page 105: MCQ R2

Clinical Features

• Travel history - Travel to areas with endemic

mycosis or a high prevalence of tuberculosis

• Occupational risk factors - Exposure to asbestos,

radon, nickel, chromium, vinyl chloride, and

polycyclic hydrocarbons

Solitary pulmonary nodule

Manocha S, Sharma S. Solitary pulmonary nodule. http://www.emedicine.com/radio/topic782.ht

Page 106: MCQ R2

Radiographic features

• Size

• Border

• Calcification

• Density

• Growth

• Metabolic activity

Page 107: MCQ R2

Size

• Generally, smaller nodule, more likely to be

benign

• 80% of benign nodules are less than 2 cm in

diameter

• Small size alone not exclude lung cancer

- 15% of malignant are less than 1 cm

- 42% are less than 2 cm

Solitary pulmonary nodule

Page 108: MCQ R2

Margins and Contours

• Smooth, most are benign, not at all: 21% of

malignant have well-defined margins

• Lobulated implies uneven growth, up to 25% of

benign nodules

• Irregular: more malignant

• Spiculated (sunburst or corona radiata

appearance): 84-90% are malignant

Solitary pulmonary nodule

Low

Hign

Page 109: MCQ R2

benign malignant

smooth lobulated Irregular and spiculated

Margin and Contour

Page 110: MCQ R2

Internal Characteristics

• Overlap of benign and malignant

• Homogeneous attenuation: benign (55%) and

malignant (20%)

• Air bronchograms and Pseudocavitation:

bronchioloalveolar cell carcinoma or lymphoma

Solitary pulmonary nodule

Page 111: MCQ R2

Solitary pulmonary nodule

Bronchioloalveolarcell carcinoma: pseudocavitation

Erasmus JJ. Radiographics 2000;20:43-58

Air bronchogram:lymphoma

Page 112: MCQ R2

Benign

Diffuse Central Popcorn Laminar

Indeterminant ;likely malignant

Stipple Eccentric

Calcification

most often seen in hamartomas

typical of a granuloma

Page 113: MCQ R2

Solitary pulmonary nodule

Time

• Volume Doubling time: most malignant = 30-400

days

• SPN that stable over 2-year indicator of benignity

*Yankelevitz, Am J Roentgenol 1997;168:325-8

Page 114: MCQ R2

Satellite nodule

• Tiny nodules associate with dominant pulmonary nodule

• High likelihood to be benign

• PPV for benignity: approximately 90%

Solitary pulmonary nodule

Page 115: MCQ R2

Feature or Characteristic LR

Spiculated margin

Size > 3 cm

Age > 70 yr

Malignant growth rate

Smoker

Upper lobe location

Size < 1 cm

Smooth margins

30-39 yr

Never smoked

20-29 yr

Benign calc

Benign growth rate

5.54

5.23

4.16

3.40

2.27

1.22

0.52

0.30

0.24

0.19

0.05

0.01

0.01

LRs for Selected Radiologic Features of Nodules and Patient Characteristics

(Erasmus JJ. Radiographics 2000;20:59-66)

Solitary pulmonary nodule

Page 116: MCQ R2
Page 117: MCQ R2
Page 118: MCQ R2

A 60-year-old nonsmoker female with a 2-cm left upper lung nodule found on her check-up. She was asymptomatic and chest CT scan showed no evidence of hilar or mediastinal adenopathy but eccentric calcification was demonstrated within the nodule. What is the most appropriate management?

B. Follow up CXR within 2 months

C. Review her last year CXR, if available

D. Empirical treatment with anti-TB drugs: HRZE

E. Percutaneous transthoracic needle aspiration

Page 119: MCQ R2
Page 120: MCQ R2

Feature or Characteristic LR

Spiculated margin

Size > 3 cm

Age > 70 yr

Malignant growth rate

Smoker

Upper lobe location

Size < 1 cm

Smooth margins

30-39 yr

Never smoked

20-29 yr

Benign calc

Benign growth rate

5.54

5.23

4.16

3.40

2.27

1.22

0.52

0.30

0.24

0.19

0.05

0.01

0.01

LRs for Selected Radiologic Features of Nodules and Patient Characteristics

(Erasmus JJ. Radiographics 2000;20:59-66)

Solitary pulmonary nodule

Page 121: MCQ R2
Page 122: MCQ R2
Page 123: MCQ R2

A 75 year old man with severe dementia is found to have a 3 cm nodule in Right lower lobe. He smoked 30 pack years and quit after develop dementia. His family bought him to nursing home last 2 year because of no care giver at home. A CXR at 2 years ago was within normal limit.

Which of the following is the MOST appropiatemanagement?

A. Symptomatic and supportive treatmentB. Repeat CXR in next 3 monthsC. Inform his family and discuss the most likely

diagnosis and prognosisD.Obtain CT chest include upper abdomenE. Request for diagnosis bronchoscopy

Page 124: MCQ R2

A 75 year old man with severe dementia is found to have a 3 cm nodule in Right lower lobe. He smoked30 pack years and quit after develop dementia. His family bought him to nursing home last 2 year because of no care giver at home. A CXR at 2 years ago was within normal limit.

Which of the following is the MOST appropiatemanagement?

Page 125: MCQ R2

Feature or Characteristic LR

Spiculated margin

Size > 3 cm

Age > 70 yr

Malignant growth rate

Smoker

Upper lobe location

Size < 1 cm

Smooth margins

30-39 yr

Never smoked

20-29 yr

Benign calc

Benign growth rate

5.54

5.23

4.16

3.40

2.27

1.22

0.52

0.30

0.24

0.19

0.05

0.01

0.01

LRs for Selected Radiologic Features of Nodules and Patient Characteristics

(Erasmus JJ. Radiographics 2000;20:59-66)

Solitary pulmonary nodule

Page 126: MCQ R2

A 75 year old man with severe dementia is found to have a 3 cm nodule in Right lower lobe. He smoked 30 pack years and quit after develop dementia. His family bought him to nursing home last 2 year because of no care giver at home. A CXR at 2 years ago was within normal limit.

Which of the following is the MOST appropiatemanagement?

A. Symptomatic and supportive treatmentB. Repeat CXR in next 3 monthsC. Inform his family and discuss the most likely

diagnosis and prognosisD.Obtain CT chest include upper abdomenE. Request for diagnosis bronchoscopy

Page 127: MCQ R2
Page 128: MCQ R2
Page 129: MCQ R2
Page 130: MCQ R2

A 55-year-old man with previous history of stroke came to your clinic for smoking cessation program. He smokes15 cigarettes/day. He begins his first cigarette of the day after breakfast, and the remaining after lunch and dinner.What is the most appropriate method for smoking cessation in this patient?

A. cold turkey

B. cold turkey + behavioral therapy

C. cold turkey + behavioral therapy + bupropion

D. cold turkey + behavioral therapy + varenicline

E. cold turkey + behavioral therapy + nicotine

replacement therapy

Page 131: MCQ R2

Smoking Cessation

NONPHARMACOLOGIC INTERVENTION 5A (ASK,

ADVISE, ASSESS, ASSIST, ARRANGE) : COLD TURKEY +

BEHAVIORAL THERAPY

First line Medication

Nicotine Replacement Therapy : Gum, Patch

Bupropion SR

Varenicline

Combination therapy

Page 132: MCQ R2
Page 133: MCQ R2
Page 134: MCQ R2
Page 135: MCQ R2
Page 136: MCQ R2

A 55-year-old man with previous history of stroke came to your clinic for smoking cessation program. He smokes15 cigarettes/day. He begins his first cigarette of the day after breakfast, and the remaining after lunch and dinner.What is the most appropriate method for smoking cessation in this patient?

A. cold turkey

B. cold turkey + behavioral therapy

C. cold turkey + behavioral therapy + bupropion

E. cold turkey + behavioral therapy + nicotine

replacement therapy

Page 137: MCQ R2
Page 138: MCQ R2
Page 139: MCQ R2
Page 140: MCQ R2
Page 141: MCQ R2
Page 142: MCQ R2

< 80%

Page 143: MCQ R2
Page 144: MCQ R2

250/31080%

Page 145: MCQ R2

76. Which of the following is not likely to be the potential underlying cause of bronchiectasis?

A. Kartagener's syndrome B. Churg Strauss syndrome C. PanhypogammaglobulinemiaD. Endobronchial carcinoid tumor E. Allergic bronchopulmonary aspergillosi

Page 146: MCQ R2

สาเหตขุอง bronchiectasis

1. Airway obstruction เชน่ endobronchial tumor, foreign body2. Defective host defenses เชน่ hypogammaglobulinemia3. Cystic fibrosis 4. Young's syndrome combination of obstructive azoospermia (with normal spermatogenesis) and chronic sinopulmonary infections (bronchiectasis and sinusitis)5. Rheumatic and other systemic diseases เชน่ rheumatoid arthritis และ Sjögren's syndrome6. Dyskinetic cilia เชน่ Kartagener's syndrome 7. Alpha-1 antitrypsin deficiency 8. Pulmonary infections เชน่ TB9. Allergic bronchopulmonary aspergillosis

Page 147: MCQ R2

76. Which of the following is not likely to be the potential underlying cause of bronchiectasis?

A. Kartagener's syndrome

C. PanhypogammaglobulinemiaD. Endobronchial carcinoid tumor E. Allergic bronchopulmonary aspergillosis

Page 148: MCQ R2

53. A 35-year-old male is evaluated of infertility. Sperm analysis shows a normal number of sperm, but they are immotile. Past medical history is notable for recurrent sinopulmonary infections. Which of the following CXR is related to this patient?

A. Bihilar lymphadenopathy

B. Normal chest radiography

C. Water balloon–shaped heart

D. Bilateral upper lobe infiltrates

E. Situs inversus and diffuse reticular infiltration

Page 149: MCQ R2

A 35-year-old male is evaluated of infertility. Sperm analysis shows a normal number of sperm, but they are immotile. Past medical history is notable for recurrent sinopulmonary infections. Which of the following CXR is relate to this patients?

Page 150: MCQ R2

Manes Kartagener first recognized this clinical triad

is inherited via an autosomal recessive pattern

Symptoms result from defective cilia motility

Kartagener’s syndrome

bronchiectasis situs inversuschronic sinusitis

Immotile spermatozoa or infertility

Confirmation with biopsy of respiratory mucosa or microscopic examination of sperms

Page 151: MCQ R2
Page 152: MCQ R2

A 35-year-old male is evaluated of infertility. Sperm analysis shows a normal number of sperm, but they are immotile. Past medical history is notable for recurrent sinopulmonary infections. Which of the following CXR is related to this patient?

A. Bihilar lymphadenopathy

B. Normal chest radiography

C. Water balloon–shaped heart

D. Bilateral upper lobe infiltrates

Page 153: MCQ R2

A flow volume loop of spirometry shows plateau of the inspiratory loop only. What is the most likely cause of this pattern?

A. Small airways narrowing

B. Fixed intra-thoracic obstruction

C. Fixed extra-thoracic obstruction

D. Variable intra-thoracic obstruction

E. Variable extra-thoracic obstruction

Page 154: MCQ R2

Spirometry in Upper Airway Obstruction

Extrathoracic airway Intrathoracic airway

Nose, mouth, pharynx, larynx and the 2 to 4 cm. of the trachea cephaled to the thoracic inlet

Trachea to the main carina

Page 155: MCQ R2

Variable Extrathoracic Obstruction

0

-

- -

0 0

+ +

+

0

0 0

Page 156: MCQ R2

Variable Intrathoracic Obstruction

- --

0

0 0

+ ++

0

00

Page 157: MCQ R2

Fixed Obstruction

Page 158: MCQ R2
Page 159: MCQ R2

A flow volume loop of spirometry shows plateau of the inspiratory loop only. What is the most likely cause of this pattern?

A. Small airways narrowing

B. Fixed intra-thoracic obstruction

C. Fixed extra-thoracic obstruction

D. Variable intra-thoracic obstruction

Page 160: MCQ R2
Page 161: MCQ R2

Interpretation of spirometry

• Adequate or inadequate test

• Obstructive, restrictive or combine pattern

• If obstructive disease,response to bronchodilator

• Severity

• Flow-Volume loop

Page 162: MCQ R2

Adequate or inadequate

• No artifacts : cough or glottic closure, leak, early termination, obstructed mouthpiece

• Sharp peak flow (time to PEF < 120msec.)

• Expiratory duration greater than 6 seconds or plateau in volume time curve

• Age, sex, height

• 2/3 highest FEV1 , FVCvariation < 0.2L (reproducibility)

Page 163: MCQ R2

Normal Spirometry

Page 164: MCQ R2

Reproducible

Page 165: MCQ R2

Early Terminate

Page 166: MCQ R2

COUGH

Page 167: MCQ R2

Poor Effort

Page 168: MCQ R2

Poor Effort

Page 170: MCQ R2

What is pattern of spirometry?

• FEV1/FVC ปกตหิรือผิดปกติ (75%)

• ถ้าผิดปกตเิข้าได้กบั airflow limitation ให้ดตูอ่ว่า

– FVC - FEV1 15 pure obstructive pattern

– FVC - FEV1 < 15 อาจมี restrictive ร่วมด้วย

Page 171: MCQ R2

What is pattern of spirometry?

• ถ้า FEV1/FVC ปกตใิห้ด ูFEV1, FVC วา่ปกติหรือต ่า (ปกติ >

80%)– ถ้าต ่าและ

• FEV1>FVC เข้าได้กบั restrictive pulmonary disease

• FEV1<FVC เข้าได้กบั mixed obstructive with restrictive

pulmonary disease

– ถ้าปกติ ให้ด ูFEF25-75 วา่มากหรือน้อยกวา่ 65%

• ถ้ามากกวา่ 65% ถือวา่ normal PFT

• ถ้าน้อยกวา่ 65% แปลผลเป็น small airway disease

Page 172: MCQ R2

Response to bronchodilator

• เทียบ pre-post bronchodilator 15 min.

• FEV1,FVC improved 12%(15%) and 200cc.

• FEF25-75 improved 35%

Page 173: MCQ R2

FEV1/FVC

obstructive FEV1,FVC

restrictive

FEF 25-75

normal Small airway disease

<75% 75%

abnormal normal

65% <65%

FVC-FEV1

Pure obstructive

Possible mixed restrictive

<15%>15%FVC<FEV1 FVC>FEV1

Mixed obstructive with restrictive

Page 174: MCQ R2

Severity

• Obstructive

Mild Moderate Severe

60-79% 41-59% 40%

• Restrictive

Mild Moderate Severe

60-79% 51-59% 50%

Page 175: MCQ R2

Flow-Volume Loop

Page 176: MCQ R2

Emphysema

Page 177: MCQ R2

Extra thoracic Obstruction

Page 178: MCQ R2

Intra thoracic Obstruction

Page 179: MCQ R2

Fixed Obstruction

Page 180: MCQ R2
Page 181: MCQ R2
Page 182: MCQ R2
Page 183: MCQ R2

An asthmatic patient’s spirometry reveal FEV1 of 1000 mlFVC 2000 ml FEV1/FVC 50%. After salbutamol inhalation, which spirometric results show the best bronchodialtorresponse?

A. FEV1 1100 ml FVC 2000 ml FEV1/FVC 55%B. FEV1 1100 ml FVC 1500 ml FEV1/FVC 73%C. FEV1 1200 ml FVC 2200 ml FEV1/FVC 54%D. FEV1 1000 ml FVC 1200 ml FEV1/FVC 83%E. FEV1 900 ml FVC 2100 ml FEV1/FVC 55%

Page 184: MCQ R2

Response to bronchodilator

• เทียบ pre-post bronchodilator 15 min.

• FEV1,FVC improved 12%(15%) and 200cc.

• FEF25-75 improved 35%

Page 185: MCQ R2

An asthmatic patient’s spirometry reveal FEV1 of 1000 mlFVC 2000 ml FEV1/FVC 50%. After salbutamol inhalation, which spirometric results show the best bronchodialtorresponse?

A. FEV1 1100 ml FVC 2000 ml FEV1/FVC 55%B. FEV1 1100 ml FVC 1500 ml FEV1/FVC 73%C. FEV1 1200 ml FVC 2200 ml FEV1/FVC 54%D. FEV1 1000 ml FVC 1200 ml FEV1/FVC 83%E. FEV1 900 ml FVC 2100 ml FEV1/FVC 55%

Page 186: MCQ R2
Page 187: MCQ R2

DDx orthopneaCHFV/Q mismatch in posteria part of lungdiaphragmatic paralysis

Page 188: MCQ R2

Unilateral diaphragmatic paralysis

Phrenic nerve injury

Herpes zoster, poliomyelitis, and other viral infections

Cervical spondylosis

Clinical manifestations

usually asymptomatic at rest

may have exertional dyspnea and decreased exercise performance

Imaging

CXR upright elevated hemidiaphragm

PFT

FVC decrease 15-20% in supine position

Page 189: MCQ R2

Bilateral diaphragmatic paralytic

Etiology

• Spinal cord disease

• Motor neuron disease

• Neuropathy

• Neuromuscular junction disease

• Muscle disease

Page 190: MCQ R2

Symptom

orthopnea

PE

abdominal wall paradox

hypoxemia

CXR

bilateral, smooth elevation of the hemidiaphragms and small lung volumes

PFT

FVC may decrease 15 to 25 percent in the supine position

Page 191: MCQ R2
Page 192: MCQ R2

Pulmonary embolism

Symptomsdyspneapleuritic chest painsubsternal chest paincoughhemoptysissyncope

Signstachycardiatachypneasign of DVTfevercyanosis

Page 193: MCQ R2
Page 194: MCQ R2
Page 195: MCQ R2
Page 196: MCQ R2
Page 197: MCQ R2
Page 198: MCQ R2
Page 199: MCQ R2

On the first day following a cesarean section, the patient complains of acute shortness of breath. Her respiratory rate is 26/min. Her pulse is 112/min. Her oxygen saturation is 85% on room air. Her lung are clear. Homan’s sign is negative. What is

the most likely diagnosis?

1. Pneumonia

2. Atelectasis

3. Popliteal thrombosis with PE

4. Iliofemoral thrombosis with PE

5. Pulmonary edema

Page 200: MCQ R2

On the first day following a cesarean section, the patient complains of acute shortness of breath. Her respiratory rate is 26/min. Her pulse is 112/min. Her oxygen saturation is 85% on room air. Her lung are clear. Homan’s sign is negative. What is the most

likely diagnosis?

1. Pneumonia

2. Atelectasis

3. Pulmonary edema

Page 201: MCQ R2

The risk for thrombosis is increased in pregnancy, partly because of the increase in the coagulation factors, particularly V, VIII, X, and von Willebrand factor Ag, and partly because of a marked fall in protein S Venous stasis, an important contributor to thrombosis, is caused by uterine compression of the inferior vena cava and the left iliac vein Local trauma to pelvic veins at the time of delivery probably accounts for the peak incidence of thromboembolism in the postpartum period, especially after cesarean section.

Pulmonary Embolism

Page 202: MCQ R2

On the first day following a cesarean section, the patient complains of acute shortness of breath. Her respiratory rate is 26/min. Her pulse is 112/min. Her oxygen saturation is 85% on room air. Her lung are clear. Homan’s sign is negative. What is

the most likely diagnosis?

1. Pneumonia

2. Atelectasis

3. Popliteal thrombosis with PE

4. Iliofemoral thrombosis with PE

5. Pulmonary edema

Page 203: MCQ R2

A 25 year old man was intubated on A/C mode ventilation for status asthmaticus. He was sedated and paralyzed. His lung examination showed expiratory rhochi diffusely.

The set tidal volume was 400 cc., RR 15/min, FiO2 0.4, PEEP of 0 cmH2O, PF 80 L/min. PIP 38 cmH2O Ppla 25 cmH2O TV 300-400 cc O2 sat 99%. The patient was given NB

salbutamol q 1 hr, IV steroid, tube feeding and IV fluid. He had positive fluid balance of 1500 cc/day during the past 2 days. On third day of admission, his ventilator alarm went off. The ventilator setting were not changed. His lung examination showed no wheeze,

the PIP was 50 cmH2O and Ppla 26 cmH2OWhich one of these condition would be the cause of the ventilator alaem?

1.Fluid overload2.Pneumothorax3.HAP4.Lt.lung atelectasis5.Bited on the ET tube

Page 204: MCQ R2

A 25 year old man was intubated on A/C mode ventilation for status asthmaticus. He was sedated and paralyzed. His lung examination showed

expiratory rhochi diffusely. The set tidal volume was 400 cc., RR 15/min, FiO2 0.4, PEEP of 0 cmH2O, PF 80 L/min. PIP 38 cmH2O Ppla 25 cmH2O TV 300-400

cc O2 sat 99%. The patient was given NB salbutamol q 1 hr, IV steroid, tube feeding and IV fluid. He had positive fluid balance of 1500 cc/day during the

past 2 days. On third day of admission, his ventilator alarm went off. The ventilator setting were not changed. His lung examination showed no wheeze,

the PIP was 50 cmH2O and Ppla 26 cmH2OWhich one of these condition would be the cause of the ventilator alaem?

↑ PIP

Peak inspiratory pressure = P resistance + P elastance

Page 205: MCQ R2

LUNG MECHANIC

Page 206: MCQ R2

LUNG MECHANICS

Paw = AIRWAY PRESSURE

Raw = RESISTANCE

Crs = COMPLIANCE

Paw = PRaw + PCrs (Pplat)

Page 207: MCQ R2

LUNG MECHANIC

PAW = PR + PE

= Pmusi

P AW =Peak airway pressure

PR = แรงตา้นจากท่อทางเดินหายใจ

PE =แรงตา้นจากการขยายตวัของ ถุงลมและผนงัทรวงอก

Pmusi = แรงของกลา้มเน้ือในการหายใจ

Page 208: MCQ R2

LUNG MECHANIC

Paw = PRaw + Pclung

Raw = Pressure (cmH2O)Flow (L/Sec)

= Pdyn - Pstat

Flow

Compliance = Volume (ml)Pressure (cmH2O)

= Volume (ml)Pstat - PEEP

Page 209: MCQ R2

Pressure Resistance

PIP 38 cmH2O Ppla 25 cmH2O

PIP was 50 cmH2O and Ppla 26 cmH2O

Page 210: MCQ R2

A 25 year old man was intubated on A/C mode ventilation for status asthmaticus. He was sedated and paralyzed. His lung examination showed expiratory rhochi diffusely.

The set tidal volume was 400 cc., RR 15/min, FiO2 0.4, PEEP of 0 cmH2O, PF 80 L/min. PIP 38 cmH2O Ppla 25 cmH2O TV 300-400 cc O2 sat 99%. The patient was given NB

salbutamol q 1 hr, IV steroid, tube feeding and IV fluid. He had positive fluid balance of 1500 cc/day during the past 2 days. On third day of admission, his ventilator alarm went off. The ventilator setting were not changed. His lung examination showed no wheeze,

the PIP was 50 cmH2O and Ppla 26 cmH2OWhich one of these condition would be the cause of the ventilator alaem?

1.Fluid overload2.Pneumothorax3.HAP4.Lt.lung atelectasis5.Bited on the ET tube

Page 211: MCQ R2
Page 212: MCQ R2
Page 213: MCQ R2
Page 214: MCQ R2
Page 215: MCQ R2
Page 216: MCQ R2
Page 217: MCQ R2

A 70 year-old man with COPD, presented with dyspneaon exertion. Physical examination revealed engorged neck vein, right ventricular heaving and pansystolic murmur grade II at left lower sternal border. His current medications were Ipratropium bromide inhaler and slow release theophylline. ABG: PaO2 53mmHg, PaCO2 45mmHg, pH7.38, O2Sat 87%. What is the most appropriate treatment?

A.PrednisoloneB.Steroid inhaler C. Inhale iloprostD.Long term oxygen therapy E. Noninvasive positive pressure ventilation

Page 218: MCQ R2

Oxygen therapy• Long term administration of oxygen (>15h/day) to

patients with chronic respiratory failure has been shown to increase survival (evidence B)

Indication for long term oxygen therapy (LTOT)

1. PaO2 < 55 mmHg or SaO2 at or below 88% with or without

hypercapnea confirmed twice over a three week period

2. PaO2 < 55mmHg or SaO2 at or below 88% if there is evidence of

pulmonary hypertension, peripheral edema suggesting congestive

cardiac failure or polycytemia( Hct>55%)

COPD and Pulmonary Hypertension

GOLD Guideline 2011

Page 219: MCQ R2

GOLD Guideline 2011

Page 220: MCQ R2

GOLD Guideline 2011

Page 221: MCQ R2

ICS + LABA

or LAMA

ICS + LABA

and

LAMA

SABA or

SAMA

LABA

or LAMA

GOLD Guideline 2011

Page 222: MCQ R2

19. A 70 year-old man with COPD, presented with dyspnea on exertion. Physical examination revealed engorged neck vein, right ventricular heaving and pansystolic murmur grade II at left lower sternal border. His current medications were Ipratropium bromide inhaler and slow release theophylline. ABG: PaO2 53mmHg, PaCO2 45 mmHg, pH7.38, O2Sat 87%. What is the most appropriate treatment?

A.PrednisoloneB.Steroid inhaler C. Inhale iloprost

E. Noninvasive positive pressure ventilation

Page 223: MCQ R2
Page 224: MCQ R2
Page 225: MCQ R2
Page 226: MCQ R2
Page 227: MCQ R2
Page 228: MCQ R2
Page 229: MCQ R2
Page 230: MCQ R2
Page 231: MCQ R2
Page 232: MCQ R2
Page 233: MCQ R2

NIVImprove respiratory acidosisDecrease RRDecrease breathlessnessDecrease VAPDecrease LOSDecrease ETTDecrease mortality

Page 234: MCQ R2
Page 235: MCQ R2
Page 236: MCQ R2

2

Page 237: MCQ R2

Clue

• AE asthma

• silent chest drowsiness air hunger on BD + steroid

• On MV : VCV vt 600 ml RR 20 PF 60 FiO2 0.6

• Paw 50 Ppl 25

• ABG: pH 7.45 PCO2 30 PO2 200

Page 238: MCQ R2

• How to set MV in asthma

– Low tidal volume

– High PF to short Ti

– Low RR

– Short Ti prolong Te

– PEEP 3-5 cmH2O : not need to adjust 80% autoPEEP

– FiO2 : lowest to keep PaO2 > 60 mmHg, SaO2 > 90%

– Set alarm

Page 239: MCQ R2

Answer

• On MV : VCV vt 600 ml RR 20 PF 60 FiO2 0.6 – Accept due to Ppl not above limit

– but accept if decrease Vt, RR, FiO2 but should avoid pH < 7.2 and PaO2 < 60

• Paw 50 Ppl 25 :– Ppl accept : set high Vt alarm to avoid volume

trauma

• ABG: pH 7.45 PCO2 30 PO2 200 – Accept but and decrease FiO2

Page 240: MCQ R2

• Mx except

1. Decrease VT

2. Decrease RR

3. PF ?

4. Decrease FiO2

5. Increase PEEP : not necessary

Page 241: MCQ R2